Kamada Balance Sheet Health

Financial Health criteria checks 6/6

Kamada has a total shareholder equity of $251.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $351.0M and $99.9M respectively. Kamada's EBIT is $16.8M making its interest coverage ratio -8.5. It has cash and short-term investments of $56.5M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-8.5x
CashUS$56.55m
EquityUS$251.15m
Total liabilitiesUS$99.89m
Total assetsUS$351.04m

Recent financial health updates

No updates

Recent updates

Kamada secures $22M extension of Canadian supply tender

Oct 19

Kamada Q2 2022 Earnings Preview

Aug 16

Kamada inks agreement for the distribution of three biosimilar products in Israel

Jan 13

Kamada Looks Cheap AS Takeda Deal Creates Value

Nov 02

Financial Position Analysis

Short Term Liabilities: KMDA's short term assets ($166.4M) exceed its short term liabilities ($40.9M).

Long Term Liabilities: KMDA's short term assets ($166.4M) exceed its long term liabilities ($59.0M).


Debt to Equity History and Analysis

Debt Level: KMDA is debt free.

Reducing Debt: KMDA has no debt compared to 5 years ago when its debt to equity ratio was 0.8%.

Debt Coverage: KMDA has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: KMDA has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies